These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 9413087)

  • 1. An immunogenicity and efficacy study of purified chick embryo cell culture rabies vaccine manufactured in Japan.
    Benjavongkulchai M; Kositprapa C; Limsuwun K; Khawplod P; Thipkong P; Chomchey P; Yountong C; Naraporn N; Ayuthya AB; Raksakate S; Samranwetaya P; Oka T; Ohkuma K; Hamasaki T; Wilde H
    Vaccine; 1997 Dec; 15(17-18):1816-9. PubMed ID: 9413087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative study on the safety and immunogenicity of Purified duck embryo vaccine [corrected] (PDEV, Vaxirab) with purified chick embryo cell vaccine (PCEC, Rabipur) and purifed vero cell rabies vaccine (PVRV, Verorab).
    Ashwathnarayana DH; Madhusudana SN; Sampath G; Sathpathy DM; Mankeshwar R; Ravish HH; Ullas PT; Behra TR; Sudarshan MK; Gangaboraiah ; Shamanna M
    Vaccine; 2009 Dec; 28(1):148-51. PubMed ID: 19818720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity and safety of purified chick-embryo cell rabies vaccine under Zagreb 2-1-1 or 5-dose Essen regimen in Chinese children 6 to 17 years old and adults over 50 years: a randomized open-label study.
    Li R; Li Y; Wen S; Wen H; Nong Y; Mo Z; Xie F; Pellegrini M
    Hum Vaccin Immunother; 2015; 11(2):435-42. PubMed ID: 25692350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized open-labeled study to demonstrate the non-inferiority of purified chick-embryo cell rabies vaccine administered in the Zagreb regimen (2-1-1) compared with the Essen regimen in Chinese adults.
    Ma J; Wang H; Li J; Chang L; Xie Y; Liu Z; Zhao Y; Malerczyk C
    Hum Vaccin Immunother; 2014; 10(10):2805-12. PubMed ID: 25483635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune response to purified chick embryo cell culture rabies vaccine manufactured in India.
    Natarajan M; Mukundan P; John TJ
    Indian J Med Res; 1992 Mar; 95():51-3. PubMed ID: 1601469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purified chick embryo cell rabies vaccine: economical multisite intradermal regimen for post-exposure prophylaxis.
    Suntharasamai P; Warrell MJ; Viravan C; Chanthavanich P; Looareesuwan S; Supapochana A; Supanaranond JK; Chittamas S; Bijok U; Warrell DA
    Epidemiol Infect; 1987 Dec; 99(3):755-65. PubMed ID: 3428378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine.
    Briggs DJ; Banzhoff A; Nicolay U; Sirikwin S; Dumavibhat B; Tongswas S; Wasi C
    Bull World Health Organ; 2000; 78(5):693-8. PubMed ID: 10859864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economical multi-site intradermal regimen with purified chick embryo cell vaccine (Rabipur) prevents rabies in people bitten by confirmed rabid animals.
    Madhusudana SN; Anand NP; Shamsundar R
    Int J Infect Dis; 2002 Sep; 6(3):210-4. PubMed ID: 12718837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and immunogenicity study of a new purified chick embryo cell rabies vaccine Vaxirab-N (Pitman-Moore strain) manufactured in India.
    Ashwath Narayana DH; Madhusudana SN; Sampath G; Tripathy RM; Sudarshan MK; Gangaboraiah ; Ravish HS; Satapathy DM; Gowda G; Holla R; Ashwin BY; Padhi A; Manjula S; Patel PM
    Hum Vaccin Immunother; 2014; 10(1):120-5. PubMed ID: 24030586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing the relationship between antigenicity and immunogenicity of human rabies vaccines. Results of a meta-analysis.
    Sudarshan MK; Mahendra BJ; Madhusudana SN; Narayana DH; Sanjay TV; Gangaboraiah ; Anandagiri MS
    Hum Vaccin; 2005; 1(5):187-90. PubMed ID: 17033270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-exposure prophylaxis (PEP) for rabies with purified chick embryo cell vaccine: a systematic literature review and meta-analysis.
    Preiss S; Chanthavanich P; Chen LH; Marano C; Buchy P; van Hoorn R; Vonk Noordegraaf M; Mukherjee P
    Expert Rev Vaccines; 2018 Jun; 17(6):525-545. PubMed ID: 29939085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protecting Indian schoolchildren against rabies: pre-exposure vaccination with purified chick embryo cell vaccine (PCECV) or purified verocell rabies vaccine (PVRV).
    Shanbag P; Shah N; Kulkarni M; Juvekar M; Madhusudana SN; Vakil HB; Malerczyk C
    Hum Vaccin; 2008; 4(5):365-9. PubMed ID: 18398307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative evaluation of immunogenicity, reactogenecity and safety of purified chick embryo cell rabies vaccine and neural tissue rabies vaccine.
    Deshpande AK; Londhe VA; Akarte S; Briggs D
    J Assoc Physicians India; 2003 Jul; 51():655-8. PubMed ID: 14621031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study on the immunogenicity and safety of a purified chick embryo cell rabies vaccine (PCECV) administered according to two different simulated post exposure intramuscular regimens (Zagreb versus Essen).
    Mahendra BJ; Narayana DA; Agarkhedkar S; Ravish HS; Harish BR; Agarkhedkar S; Madhusudana SN; Belludi A; Ahmed K; Jonnalagedda R; Vakil H; Bhusal C; Arora AK
    Hum Vaccin Immunother; 2015; 11(2):428-34. PubMed ID: 25692792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A single center, open label study of intradermal administration of an inactivated purified chick embryo cell culture rabies virus vaccine in adults.
    Recuenco S; Warnock E; Osinubi MOV; Rupprecht CE
    Vaccine; 2017 Aug; 35(34):4315-4320. PubMed ID: 28688782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One-year immunogenicity kinetics and safety of a purified chick embryo cell rabies vaccine and an inactivated Vero cell-derived Japanese encephalitis vaccine administered concomitantly according to a new, 1-week, accelerated primary series.
    Cramer JP; Jelinek T; Paulke-Korinek M; Reisinger EC; Dieckmann S; Alberer M; Bühler S; Bosse D; Meyer S; Fragapane E; Costantini M; Pellegrini M; Lattanzi M; Dovali C
    J Travel Med; 2016 Mar; 23(3):. PubMed ID: 26994987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune response to tissue culture rabies vaccine in subjects who had previous postexposure treatment with Semple or suckling mouse brain vaccine.
    Khawplod P; Wilde H; Yenmuang W; Benjavongkulchai M; Chomchey P
    Vaccine; 1996 Nov; 14(16):1549-52. PubMed ID: 9014298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pilot study on intradermal vaccination of Japanese rabies vaccine for pre-exposure immunization.
    Shiota S; Khawplod P; Ahmed K; Mifune K; Nishizono A
    Vaccine; 2008 Nov; 26(50):6441-4. PubMed ID: 18804510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the safety and immunogenicity of a new, heat-treated human rabies immune globulin using a sham, post-exposure prophylaxis of rabies.
    Lang J; Gravenstein S; Briggs D; Miller B; Froeschle J; Dukes C; Le Mener V; Lutsch C
    Biologicals; 1998 Mar; 26(1):7-15. PubMed ID: 9637744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the immunogenicity and safety of the purified chick embryo cell rabies vaccine manufactured in India and Germany: A randomized, single blind, multicentre, phase IV clinical study.
    Sampath G; Banzhoff A; Deshpande A; Malerczyk C; Arora AK; Vakil H; Preiss S
    Hum Vaccin Immunother; 2017 Jul; 13(7):1531-1538. PubMed ID: 28406752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.